March 11, 2008 – Cerner Corporation (NASDAQ: CERN), the University of New Mexico Health Sciences Center (UNMHSC) College of Pharmacy, the UNM School of Engineering and STC.UNM (STC), the University’s technology-transfer corporation, announced the signing of a Sponsored Research Agreement to evaluate UNMHSC’s dry-powder inhaler (DPI) drug-delivery technology for use in both pulmonary and systemic conditions, like asthma and chronic obstructive lung disease. Upon completion of the research studies, the agreement provides Cerner an option for exclusive licensing of UNMHSC’s technology for clinical and commercial use worldwide... Cerner 's Press Release -
Mar 11, 2008
Cerner and UNMHSC, agreement to evaluate dry-powder inhaler drug-delivery technology
March 11, 2008 – Cerner Corporation (NASDAQ: CERN), the University of New Mexico Health Sciences Center (UNMHSC) College of Pharmacy, the UNM School of Engineering and STC.UNM (STC), the University’s technology-transfer corporation, announced the signing of a Sponsored Research Agreement to evaluate UNMHSC’s dry-powder inhaler (DPI) drug-delivery technology for use in both pulmonary and systemic conditions, like asthma and chronic obstructive lung disease. Upon completion of the research studies, the agreement provides Cerner an option for exclusive licensing of UNMHSC’s technology for clinical and commercial use worldwide... Cerner 's Press Release -
